BlackRock’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Sell |
17,897,400
-35,506
| -0.2% | -$40.1K | ﹤0.01% | 2973 |
|
|
2025
Q1 | $26.2M | Sell |
17,932,906
-129,749
| -0.7% | -$189K | ﹤0.01% | 2749 |
|
|
2024
Q4 | $38.5M | Buy |
18,062,655
+289,910
| +2% | +$618K | ﹤0.01% | 2587 |
|
|
2024
Q3 | $49.8M | Buy |
17,772,745
+1,327,063
| +8% | +$3.72M | ﹤0.01% | 2441 |
|
|
2024
Q2 | $38.3M | Buy |
16,445,682
+6,792,752
| +70% | +$15.8M | ﹤0.01% | 2540 |
|
|
2024
Q1 | $43.1M | Sell |
9,652,930
-348,874
| -3% | -$1.56M | ﹤0.01% | 2477 |
|
|
2023
Q4 | $32.1M | Buy |
10,001,804
+1,107,824
| +12% | +$3.56M | ﹤0.01% | 2697 |
|
|
2023
Q3 | $28.2M | Buy |
8,893,980
+447,930
| +5% | +$1.42M | ﹤0.01% | 2698 |
|
|
2023
Q2 | $42M | Sell |
8,446,050
-677,042
| -7% | -$3.36M | ﹤0.01% | 2545 |
|
|
2023
Q1 | $45.1M | Buy |
9,123,092
+236,520
| +3% | +$1.17M | ﹤0.01% | 2479 |
|
|
2022
Q4 | $55.9M | Buy |
8,886,572
+673,992
| +8% | +$4.24M | ﹤0.01% | 2361 |
|
|
2022
Q3 | $88.7M | Buy |
8,212,580
+207,414
| +3% | +$2.24M | ﹤0.01% | 2020 |
|
|
2022
Q2 | $91.3M | Buy |
8,005,166
+918,933
| +13% | +$10.5M | ﹤0.01% | 2051 |
|
|
2022
Q1 | $64.6M | Buy |
7,086,233
+560,279
| +9% | +$5.1M | ﹤0.01% | 2395 |
|
|
2021
Q4 | $97.4M | Sell |
6,525,954
-745,238
| -10% | -$11.1M | ﹤0.01% | 2217 |
|
|
2021
Q3 | $187M | Buy |
7,271,192
+249,253
| +4% | +$6.41M | 0.01% | 1750 |
|
|
2021
Q2 | $183M | Buy |
7,021,939
+751,861
| +12% | +$19.6M | 0.01% | 1819 |
|
|
2021
Q1 | $221M | Sell |
6,270,078
-202,682
| -3% | -$7.15M | 0.01% | 1649 |
|
|
2020
Q4 | $163M | Buy |
6,472,760
+160,057
| +3% | +$4.04M | 0.01% | 1746 |
|
|
2020
Q3 | $238M | Buy |
6,312,703
+520,584
| +9% | +$19.6M | 0.01% | 1245 |
|
|
2020
Q2 | $248M | Buy |
5,792,119
+889,535
| +18% | +$38.1M | 0.01% | 1198 |
|
|
2020
Q1 | $95.3M | Sell |
4,902,584
-122,188
| -2% | -$2.38M | ﹤0.01% | 1664 |
|
|
2019
Q4 | $131M | Buy |
5,024,772
+1,020,753
| +25% | +$26.5M | 0.01% | 1785 |
|
|
2019
Q3 | $109M | Buy |
4,004,019
+441,686
| +12% | +$12M | ﹤0.01% | 1838 |
|
|
2019
Q2 | $95.7M | Buy |
3,562,333
+1,312,056
| +58% | +$35.2M | ﹤0.01% | 1930 |
|
|
2019
Q1 | $65.1M | Buy |
2,250,277
+170,448
| +8% | +$4.93M | ﹤0.01% | 2124 |
|
|
2018
Q4 | $56M | Buy |
+2,079,829
| New | +$56M | ﹤0.01% | 2164 |
|